Work

High Dose Cytarabine (HiDAC) and Mitoxantrone (MITO) Is An Effective Induction Therapy for High-Risk Acute Myeloid Leukemia (AML).

Year: 2009

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v114.22.1048.1048

Authors: Sarah Larson, Nicholas Campbell, Dezheng Huo, Andrew Artz, Yanming Zhang, Devika Gajria, Margaret Green, Gamar Rahimova, Howard Weiner, Monica Torres, Olatoyosi Odenike, Lucy A Godley, Elizabeth Shima Rich, Michael Thirman, Richard A. Larson, Wendy Stock

Institutions: University of Chicago Medical Center, University of Chicago, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2575273748

FWCI: 0.426

Cites:

Cited by: 2

Related to: 10